| Trust in a COVID-19 vaccine in the US: a social ecological perspective | Oral abstract session with live Q&A | Vaccines |
| Mask usage, social distancing, racial, and gender correlates of COVID-19 vaccine intentions among adults in the US | Oral abstract session with live Q&A | Vaccines |
| CRISPR-Cas13b can potently suppress replication of SARS-CoV-2 and mutant strains | Oral abstract session with live Q&A | Basic science |
| Social distancing 2.0 with privacy-preserving contact tracing as an alternative to lockdown for COVID-19 pandemic control | Oral abstract session with live Q&A | Non-pharmaceutical prevention |
| Synergistic effect of non-movement-restrictive social distancing, testing-and-isolation, and contact tracing-and-quarantine during the COVID-19 outbreak in Daegu, Korea, February to April 2020 | Oral abstract session with live Q&A | Non-pharmaceutical prevention |
| A balancing act of lives and livelihoods: supporting the South African government to develop a risk-adjusted strategy for economic activity during the height of COVID-19 pandemic | Oral abstract session with live Q&A | Global access and policy |
| Leveraging electronic management information systems to enhance and optimize supply chain response during public health emergencies: lessons from COVID-19 response in Uganda | Oral abstract session with live Q&A | Global access and policy |
| New head-to-head clinical trials of COVID-19 vaccines ' issues with trial design and primary endpoints | Oral abstract session with live Q&A | no category |
| Non-pharmaceutical interventions to mitigate spread of SARS-CoV-2 in Shenzhen, China: a modelling study | E-poster | Non-pharmaceutical prevention |
| Evolution of SARS-CoV-2 envelope, membrane, nucleocapsid and spike structural proteins from the beginning of the pandemic to September 2020: a global and regional approach by epidemiological week | Oral abstract session with live Q&A | Basic science |